Increased tendency to bruise
|
phenotype |
Wounds and Injuries
|
Finding
|
133
|
14
|
0.100 |
None |
|
0 |
|
|
|
Ecchymosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Pathologic Function
|
41
|
2
|
0.100 |
None |
|
0 |
|
|
|
Epistaxis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Pathologic Function
|
82
|
4
|
0.100 |
None |
|
0 |
|
|
|
Impaired thromboxane A2 agonist-induced platelet aggregation
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Bleeding Disorder due to Defective Thromboxane A2 Receptor
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
|
0 |
|
|
|
Atherothrombosis
|
disease |
|
Acquired Abnormality
|
115
|
15
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.100 |
None |
1.000 |
10 |
7
|
2000 |
2016 |
Cerebral Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
687
|
123
|
0.040 |
None |
1.000 |
4 |
3
|
2006 |
2015 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2014 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2014 |
BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
1
|
3
|
0.700 |
strong |
1.000 |
3 |
3
|
1993 |
1996 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.030 |
None |
1.000 |
3 |
|
2012 |
2018 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2014 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.030 |
None |
1.000 |
3 |
|
2001 |
2013 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2013 |
Asthma, Aspirin-Induced
|
disease |
Respiratory Tract Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
25
|
6
|
0.310 |
None |
1.000 |
2 |
|
2006 |
2010 |
IgE-mediated allergic asthma
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
133
|
46
|
0.020 |
None |
1.000 |
2 |
1
|
2002 |
2005 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2013 |
Rhinitis
|
disease |
Infections; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
178
|
20
|
0.310 |
None |
1.000 |
2 |
|
2002 |
2012 |
Allergic asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
371
|
55
|
0.020 |
None |
1.000 |
2 |
1
|
2002 |
2005 |
Thrombocytopenia
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
592
|
110
|
0.210 |
None |
1.000 |
2 |
|
1989 |
2020 |
Endotoxemia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
401
|
5
|
0.200 |
None |
1.000 |
2 |
|
1985 |
2005 |
Adult Erythroleukemia
|
disease |
|
Neoplastic Process
|
236
|
4
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2006 |
Acute Erythroblastic Leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
302
|
5
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2006 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2016 |